Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 06:36 am Unchanged |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
Forbion Capital Fund III Cooperatief U.A. | 5,115,121 11.130% |
0 (Unchanged) |
Filing History |
| 2021-02-11 5:12 pm Sale |
2020-12-31 | 13G | Replimune Group, Inc. REPL |
BIOTECHNOLOGY VALUE FUND L P | 0 0.000% |
-2,309,109 (Position Closed) |
Filing History |
| 2021-02-08 10:31 am Purchase |
2021-02-05 | 13G | Replimune Group, Inc. REPL |
FMR LLC | 2,626,417 5.714% |
2,626,417 (New Position) |
Filing History |
| 2020-09-17 4:50 pm Sale |
2020-09-15 | 13D | Replimune Group, Inc. REPL |
Atlas Venture Fund X, L.P. | 2,524,866 6.300% |
-436,607 (-14.74%) |
Filing History |